Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Yan GaoHai-Peng WangMeng-Xiao LiuHui GuXian-Shun YuanJumatay BiekanXi-Ming WangPublished in: European radiology (2022)
• At an early stage, patients with DCM may have myocardial fibrosis despite the absence of LGE. • T1 mapping and ECV are efficient methods for early detection of potential myocardial fibrosis. • Increased native T1 and ECV are correlated with left ventricular dilation and dysfunction in LGE-negative DCM patients.
Keyphrases
- left ventricular
- early stage
- end stage renal disease
- heart failure
- high resolution
- hypertrophic cardiomyopathy
- newly diagnosed
- chronic kidney disease
- ejection fraction
- cardiac resynchronization therapy
- acute myocardial infarction
- aortic stenosis
- mitral valve
- high density
- peritoneal dialysis
- left atrial
- prognostic factors
- liver fibrosis
- radiation therapy
- coronary artery disease
- climate change
- percutaneous coronary intervention
- atrial fibrillation
- aortic valve
- rectal cancer
- neoadjuvant chemotherapy